Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation

Andersson K-E (1988) Current concepts in the treatment of disorders of micturition. Drugs 35: 477–494

Couillard DR, Webster GD (1995) Detrusor instability. Urol Clin North Am 22: 593–612

Kelleher CI, et al (1994) Antichoinergic therapy: the need for continued surveillance (abstract 59). Neurol Urdoyn 13: 4

Lockhart JL, Shessel F, Weinstein D, Politano VA (1982) Urodynamics in women with stress and urge incontinence. Urology 20: 333–336

Nilvebrant L, et al (1997) Tolterodine — a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data. Life Sci (in press)

Ouslander et al (1988) Pharmacokinetics and clinical effects of oxybutynin in geriatric patients. J Urol 140: 47–50

Thüroff J, et al (1991) Randomised, double-blind, multicentre trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo. J Urol 145: 813–817

Yarker YE, Goa KL, Fitton A (1995) Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drugs Aging 6: 243–262